4.8 Article

Magnetic Resonance Elastography Is Superior to Acoustic Radiation Force Impulse for the Diagnosis of Fibrosis in Patients With Biopsy-Proven Nonalcoholic Fatty Liver Disease: A Prospective Study

期刊

HEPATOLOGY
卷 63, 期 2, 页码 453-461

出版社

WILEY
DOI: 10.1002/hep.28337

关键词

-

资金

  1. American Gastroenterological Association Foundation-Sucampo-ASP Designated Research Award in Geriatric Gastroenterology
  2. T. Franklin Williams Scholarship Award
  3. Atlantic Philanthropies, Inc.
  4. John A. Hartford Foundation
  5. American Gastroenterological Association [K23-DK090303]
  6. National Institutes of Health T32 training grant [5TL1TR000098]
  7. National Institutes of Health, NIDDK [K23-DK090303]
  8. GE
  9. [R01-DK106419]

向作者/读者索取更多资源

Magnetic resonance elastography (MRE), an advanced magnetic resonance-based imaging technique, and acoustic radiation force impulse (ARFI), an ultrasound-based imaging technique, are accurate for diagnosing nonalcoholic fatty liver disease (NAFLD) fibrosis. However, no head-to-head comparisons between MRE and ARFI for diagnosing NAFLD fibrosis have been performed. We compared MRE versus ARFI head-to-head for diagnosing fibrosis in well-characterized patients with biopsy-proven NAFLD. This cross-sectional analysis of a prospective cohort involved 125 patients (54.4% female) who underwent MRE, ARFI, and contemporaneous liver biopsies scored using the Nonalcoholic Steatohepatitis Clinical Research Network histological scoring system. The performances of MRE versus ARFI for diagnosing fibrosis were evaluated using area under the receiver operating characteristic curves (AUROCs). The mean (6 standard deviation) age and body mass index were 48.9 (+/- 15.4) years and 31.8 (+/- 7.0) kg/m(2), respectively. For diagnosing any fibrosis (>= stage 1), the MRE AUROC was 0.799 (95% confidence interval [CI] 0.723-0.875), significantly (P=0.012) higher than the ARFI AUROC of 0.664 (95% CI 0.568-0.760). In stratified analysis by presence or absence of obesity, MRE was superior to ARFI for diagnosing any fibrosis in obese patients (P < 0.001) but not in nonobese patients (P=0.722). The MRE AUROCs for diagnosing >= stages 2, 3, and 4 fibrosis were 0.885 (95% CI 0.816-0.953), 0.934 (95% CI 0.863-1.000), and 0.882 (95% CI 0.729-1.000); and the ARFI AUROCs were 0.848 (95% CI 0.7760.921), 0.896 (95% CI 0.824-0.968), and 0.862 (95% CI 0.721-1.000). MRE had higher AUROCs than ARFI for discriminating dichotomized fibrosis stages at all dichotomization cutoff points, but the AUROC differences decreased as the cutoff points (fibrosis stages) increased. Conclusion: MRE is more accurate than ARFI for diagnosing any fibrosis in NAFLD patients, especially those who are obese.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据